Made With Uberflip Content Marketing

Erin Righetti

Editor-in-Chief, Insight

  • Starting a biotech company: What every entrepreneur needs to know

    Starting a biotech company: What every entrepreneur needs to know

    Just released: The Biotech Startup Manual. This report distills the insights, wisdom, and inspiration from a carefully selected group of industry pioneers on what it truly takes to start a...

    Read
  • EBD Academy brings executive-level leadership skills to you

    EBD Academy brings executive-level leadership skills to you

    Executive education is a critical component of business effectiveness. Business development senior management, executive management, and management teams perform at the highest level of an...

    Read
  • Bayer East Coast Innovation Center Head reveals early strategic advantage is something pharma wants from biotech startups

    Bayer East Coast Innovation Center Head reveals early strategic advantage is something pharma wants from biotech startups

    Partnering Insight recently had the pleasure of speaking with Dr. Chandra Ramanathan, Head of the East Coast Innovation Center at Bayer, whose mission is building an innovative product portfolio...

    Read
  • Biotech Startups: Land and conduct a successful investor meeting

    Biotech Startups: Land and conduct a successful investor meeting

    Biotech startup companies face many challenges, but one of the most common is landing and conducting meetings with potential investors. The following are pieces of advice from investors on what...

    Read
  • The Advocate of Rare Disease Advocates: Remembering Henri Termeer

    The Advocate of Rare Disease Advocates: Remembering Henri Termeer

    We were saddened to come to work Monday morning to discover that innovator, industry giant and Genzyme founder Henri Termeer had died. We had the pleasure of working with Termeer over the years as...

    Read
  • The Digital Medicine Crystal Ball

    The Digital Medicine Crystal Ball

    How will digital technologies impact disease management and healthcare over the next decade? Find out in the just-released whitepaper, “The Digital Medicine Crystal Ball: Unlocking the Future of...

    Read
  • Where to start: How to gain a foothold in the China biopharmaceutical market

    Where to start: How to gain a foothold in the China biopharmaceutical market

    The China pharmaceutical market has come of age. With record breaking investments in innovative companies, support from the CFDA, and new product approvals pending, China has entered a new age as...

    Read
  • Bruce Levine is a man you can thank for your future cell therapy

    Bruce Levine is a man you can thank for your future cell therapy

    To call Bruce Levine, PhD, an innovator in the cell and gene therapy space is a gross understatement. He is known for his groundbreaking work in the development and use of synthetic immune cells...

    Read
  • Rare Disease Foundation CEO cites collaboration, data sharing as keys to progress

    Rare Disease Foundation CEO cites collaboration, data sharing as keys to progress

    An interview with Monica Weldon, President of Bridge the Gap – SYNGAP Education and Research Foundation Houston-based Monica Weldon is a mother, wife, former teacher and a rare disease advocate...

    Read
  • BIO-Europe Spring 2017 kicks off this week in Barcelona

    BIO-Europe Spring 2017 kicks off this week in Barcelona

    Read
  • BIO-Europe Spring 2017 kicks off this week in Barcelona

    BIO-Europe Spring 2017 kicks off this week in Barcelona

    BIO-Europe Spring® international partnering conference kicked off yesterday in Barcelona with an estimated 2,500 attendees representing executives from the life sciences, including nearly 200...

    Read
  • World RARE Disease Day shines a light on rare disease community

    World RARE Disease Day shines a light on rare disease community

    Tomorrow is the 10th annual World RARE Disease Day. Various activities are taking place all over the United States as well as countless locations around the world. World RARE Disease Day is an...

    Read
  • Barcelona biotech companies shine light on regional entrepreneurship

    Barcelona biotech companies shine light on regional entrepreneurship

    Investors are always on the lookout for innovative biotech startups, and the Catalonia, Spain biopharma cluster has plenty to offer in the way of innovation from among its member companies....

    Read
  • What’s the deal with Immuno-oncology partnering?

    What’s the deal with Immuno-oncology partnering?

    Insight wanted to get the lay of the I/O landscape, so who better to speak with than Jeff Bockman, Vice President of Defined Health. Not only was Jeff kind enough to share his insights with us,...

    Read
  • Barcelona’s GP Pharm considers partnering key to international expansion

    Barcelona’s GP Pharm considers partnering key to international expansion

    Barcelona is an attractive location for business and trade, and has experienced a revival in the biopharma sector in recent years with the outsourcing of innovation from pharma companies to...

    Read
  • Unmet needs, uncommon commitment: The shift toward investment in rare diseases

    Unmet needs, uncommon commitment: The shift toward investment in rare diseases

    Join biotech leaders, emerging innovators, investors and patient advocacy group reps for a candid, interactive and enlightening discussion about rare disease drug discovery and development. Read...

    Read
  • Rare diseases, rare commitment

    Rare diseases, rare commitment

    Patients, their families and patient foundations are invaluable in helping drug developers understand the day-to-day realities of approx. 7,000 rare diseases (of which only 400 have therapies)....

    Read
  • The state of cell and gene therapy: Reimbursement and manufacturing dominate

    The state of cell and gene therapy: Reimbursement and manufacturing dominate

    The number of cell therapies in clinical trials has grown 21 percent since 2015, with more than 759 trials underway globally. With that growth it is time for the industry to get serious about...

    Read
  • UK Establishment upbeat about Brexit’s effect on British life science industry

    UK Establishment upbeat about Brexit’s effect on British life science industry

    Brexit may no longer be at the top of popular news, but it continues to be a key concern for biopharma companies in post-Brexit 2017. The sentiment of key players from the UK life sciences from a...

    Read
  • Lifetime trends in biopharmaceutical innovation: Recent evidence and implications

    Lifetime trends in biopharmaceutical innovation: Recent evidence and implications

    Guest blog post by Murray Aitken, Executive Director of the QuintilesIMS Institute Adequate returns on life sciences investments underpin the sustainability of the innovation lifecycle.   And...

    Read
  • loading
    Loading More...